The aim of this study was to assess the potential nutritive value for sheep, of two drought tolerant leguminous shrubs (Cassia sturtii and Sutherlandia microphylla) in terms of chemical composition, degradation parameters, digestibility, rumen fermentation parameters, intake, microbial nitrogen synthesis and nitrogen balance as well as the rumen kinetics when compared to that of Medicago sativa. The crude ash concentration of all three forages differs, with S. microphylla and C. sturtii lower than M. sativa. M. sativa has a crude ash concentration almost twice the amount of both S. microphylla and C. sturtii. Wilcock et al., (2004) reported ash values for C. sturtii stems and leaves of 53 and 73 g/kg and that of S. microphylla at 25 and 64g/kg respectively. Values for C. sturtii are lower while those of S. microphylla compare well to the average of the whole plant. The mean CP and CF concentration differed between species with C. sturtii having the lowest CP and M. sativa the highest. S. microphylla had the highest CF while M. sativa had the lowest. The NDF and ADF levels of the samples varied between all three species with S. microphylla being the highest and M. sativa the lowest. Values for C. sturtii were in between those of the two other forages. The ADL concentration of S. microphylla was higher than both C. sturtii and M. sativa. The degree of lignification in C. sturtii was high (23.8% of NDF was ADL). The degree of lignification of S. microphylla was 26.8%, which is higher than that of C. sturtii, while M. sativa is the same as C. sturtii. The calcium concentrations of C. sturtii and M. sativa are similar and have a higher concentration than S. microphylla. M. sativa and C. sturtii had a higher phosphorus concentration than S. microphylla. With respect to magnesium (Mg), C. sturtii and M. sativa have a similar composition while S. microphylla has a lower concentration. The iron concentration of all three plants differs, with M. sativa having the lowest concentration and C. sturtii the highest. The copper concentrations in M. sativa and C. sturtii were similar, while that of S. microphylla was slightly lower. The zinc concentrations in M. sativa and C. sturtii were similar, while that of S. microphylla was slightly higher. Manganese concentration of all three species differs, with C sturtii being the lowest and S. microphylla the highest. The plants from this trial were analysed for selenium but none or very insignificant levels were found and were not worth reporting. The apparent DM digestibility of S. microphylla is significantly lower than M. sativa while it did not differ significantly from C. sturtii. C. sturtii did not differ significantly from both M. sativa and S. microphylla. The CP digestibility of all three species did not differ significantly, however that of M. sativa is numerically higher. With regards to the apparent NDF digestibility, C. sturtii and S. microphylla differ significantly to M. sativa with lower NDF digestibility values. The apparent OM digestibility followed the same trend as that of apparent DM digestibility. The average intake was very different between species, with C. sturtii being the lowest and M. sativa the highest. The animals consuming either C. sturtii or S. microphylla tended to lose body weight during the experimental period, while those eating M. sativa gained body weight. Voluntary intake parameters of C. sturtii and S. microphylla were lower and differed significantly between M. sativa. The DM intake of M. sativa was higher than both C. sturtii and S. microphylla. The ME was the highest for M. sativa while S. microphylla was significantly different and had the lowest value. C. sturtii had an ME value similar to both M. sativa and S. microphylla. The ME intake of S. microphylla was 2.89 MJ/day compared to that of M. sativa of 8.57 MJ/day. Rumen NH3-N concentrations of C. sturtii were the lowest and differed significantly from S. microphylla and M. sativa. Sheep receiving C. sturtii had the lowest total rumen VFA concentration and was significantly different from M. sativa which had the highest value. S. microphylla had a similar total VFA concentration to both C. sturtii and M. sativa. C. sturtii had the lowest proportion of acetate but did not differ significantly compared to S. microphylla, while both were significantly different to M. sativa, which had the highest value. The propionate concentration for all three forages did not differ significantly. S. microphylla had the highest fibre concentration, therefore leading to higher acetate concentrations than C. sturtii but not higher than M. sativa, suggesting the fibre of S. microphylla is less digestible. This is supported by the low apparent NDF digestibility for S. microphylla. Nitrogen intake was highest for M. sativa and was significantly different from C. sturtii and S. microphylla. The same trend followed for faecal and urinary nitrogen output as well as nitrogen retention. The nitrogen retention for all species was positive with C. sturtii being the lowest. These values compare well to the CP content of the three forages with C. sturtii the lowest and M. sativa the highest concentration. The daily urinary allantoin elimination did not differ between C. sturtii and S. microphylla but was significantly different and higher for M. sativa. The amount of microbial nitrogen supplied to the animal (g/day and g/kg DOMI) followed the same trend as allantoin. M. sativa had significantly higher a-values (soluble fraction) for both DM and NDF degradation compared to the two shrub species at a rate constant of 0.02/h. C. sturtii had a higher b-value (potentially degradable fraction) for DM degradation compared to S. microphylla which shows that S. microphylla DM component was most readily soluble. For NDF, however, the b-values didn’t differ among the species. Species had also no effect on the c-values (rate of degradation of the potentially degradable fraction b) of both DM and NDF. Therefore all species appear to have a similar potential source of energy for use by micro-organisms in the rumen. Effective DM degradability of C. sturtii and S. microphylla was similar while that of M. sativa was significantly higher. The effective NDF degradability for C. sturtii and S. microphylla was similar and M. sativa again had a significantly higher NDF degradability. The rumen DM degradability for all three species showed a similar trend but much higher values than the apparent DM digestibility. The rumen NDF degradability values were almost identical to those reported for apparent NDF digestibility. The rate of intake and rate of digestion for C. sturtii and S. microphylla did not differ significantly, while that of M. sativa was the highest and significantly different. The rate of passage for all three species was similar. The percent NDF digested in the rumen differed significantly between all three species with C. sturtii being the lowest and M. sativa the highest. The percent NDF passing from the rumen also differed significantly between all three species, however this time C. sturtii being the highest and M. sativa the lowest, which corresponds well to the values for NDF digested in the rumen. It is concluded that C. sturtii and S. microphylla are of a slightly lower nutritional value for sheep than M. sativa. If these two leguminous fodder species were to be used as maintenance feed, some other supporting source of energy would need to be supplied in order for these sheep to be maintained over a long period. The negative effect of all fibre related parameters (CF, NDF, ADF and ADL) in C. sturtii and S. microphylla, reduced digestibility as well as intake, leading to a forage of lower nutrient value as compared to M. sativa. The effect of anti-nutritional factors present in C. sturtii and S. microphylla on the digestibility of forages and nutrient contribution from forages needs to be studied to determine if these play a role in reducing the nutritional value. Copyright / Dissertation (MSc(Agric))--University of Pretoria, 2013. / Animal and Wildlife Sciences / unrestricted

Thesis (MSc (Biochemistry))--University of Stellenbosch, 2009. / ENGLISH ABSTRACT: This study: 1. describes the preparation of a methanol extract of Sutherlandia frutescens and the HPLC fractionation of the methanol extract. 2. investigates the influence of S. frutescens on the binding properties of mitochondrial cytochrome 11 -hydroxylase (CYP11B1) to deoxycorticosterone (DOC) and deoxycortisol, demonstrating that methanol extracts of S. frutescens inhibit the Type I substrate-induced difference spectra. 3. investigates the influence of S. frutescens on the catalytic activity of CYP11B1 expressed in COS1 cells, demonstrating that the methanol extract of S. frutescens inhibits the conversion of DOC and deoxycortisol. 4. describes the sequential extraction of the methanol extract of S. frutescens using organic solvents and the inhibition of the conversion of DOC by CYP11B1 expressed in COS1 cells in the presence of these extracts. 5. describes the inhibition of the binding of DOC to CYP11B1 in ovine adrenal mitochondria, and the conversion of DOC by CYP11B1 expressed in COS1 cells by these fractions. 6. identifies the presence of the flavonoid compounds, orientin vitexin and rutin, in S. frutescens. 7. investigates the influence of the flavonoid compounds on the binding of DOC to CYP11B1 and on the catalytic activity of DOC by CYP11B1 expressed in COS1 cells. 8. identifies the presence of the triterpenoid, sutherlandioside A (SU1), in S. frutescens extracts and investigates its effect on the binding of DOC to CYP11B1. / AFRIKAANSE OPSOMMING: Hierdie studie beskryf: 1. die voorbereiding van ‘n metanol ekstraksie van Sutherlandia frutescens en die HPLC fraksionering van die metanol ekstrakte. 2. ‘n ondersoek na die invloed van S. frutescens op die bindingseienskappe van sitochroom P450 11 -hidroksilase (CYP11B1) in skaap bynier mitochondria en demonstreer dat S. frutescens metanol ekstrakte die vorming van steroïed-geinduseerde tipe I verskil spektra van deoksiekortisol en deoksikortikosteroon (DOC) inhibeer. 3. ‘n ondersoek na die invloed van S. frutescens op die katalitiese aktiwiteit van CYP11B1 in COS1 selle en demonstreer die inhibisie van DOC en deoksikortisol omsetting na hul produkte deur die methanol ekstrakte. 4. die opeenvolgende ekstraksie van methanol extrakte van S. frutescens met organiese oplosmiddels en beskryf die inhibisie van die CYP11B1 gekataliseerde omsetting van DOC in COS1selle in die teenwoordigheid van die ekstrakte. 5. die inhibeerende effek op die binding van DOC aan CYP11B1 in skaap bynier mitochondria en die inhibisie van die CYP11B1 gekataliseerde omsetting van DOC in COS1selle. 6. die identifisering van flavonoïed verbindings, orientin vitexin en rutin in S. frutescens. 7. ‘n ondersoek na die invloed van die flavonoïed verbindings op die binding van DOC aan CYP11B1 en op die katalitiese aktiwiteit van CYP11B1 in COS1 selle. 8. die indentifisering van die triterpenoïed, sutherlandiosied A (SU1), in S. frutescens en ondersoek die invloed van SU1 op die binding van DOC aan CYP11B1.

The overall aims of this project were to assess the pharmaceutical quality and consistency of commercially available solid dose Sutherlandia frutescens containing products (viz. tablets & capsules) by exploring the use of monitoring the pharmaceutical presentation, flavonoid profile and antioxidant activity levels and to develop/or adapt methods and specifications that may be used for the quality control of such products.Stability tests were conducted on all of the selected SCP. The products were stored under elevated temperatures and environmental humidity conditions and total phenol, antioxidant and chromatographic analysis was conducted on these samples. Samples of each of the SCP were hydrolyzed using HCL and then analyzed using HPLC to test the stability of the flavonoids present in each product. The SCP investigated in this study physically appeared to be of quite good “pharmaceutical” quality, but generally lacked information on the date of manufacture and lacked package inserts, or when these were present they contained insufficient information.Based on the results obtained, it is recommended that, the manufacturers of SCP pay more attention to the information provided on the package inserts and the storage conditions for their products. Further the levels of antioxidant activity, total phenols and flavonoid (sutherlandins A to D) be used as specifications to control the quality of commercially available solid dose Sutherlandia frutescens containing preparations on an individual basis.

The overall aims of this project were to assess the pharmaceutical quality and consistency of commercially available solid dose Sutherlandia frutescens containing products (viz. tablets & capsules) by exploring the use of monitoring the pharmaceutical presentation, flavonoid profile and antioxidant activity levels and to develop/or adapt methods and specifications that may be used for the quality control of such products.Stability tests were conducted on all of the selected SCP. The products were stored under elevated temperatures and environmental humidity conditions and total phenol, antioxidant and chromatographic analysis was conducted on these samples. Samples of each of the SCP were hydrolyzed using HCL and then analyzed using HPLC to test the stability of the flavonoids present in each product. The SCP investigated in this study physically appeared to be of quite good “pharmaceutical” quality, but generally lacked information on the date of manufacture and lacked package inserts, or when these were present they contained insufficient information.Based on the results obtained, it is recommended that, the manufacturers of SCP pay more attention to the information provided on the package inserts and the storage conditions for their products. Further the levels of antioxidant activity, total phenols and flavonoid (sutherlandins A to D) be used as specifications to control the quality of commercially available solid dose Sutherlandia frutescens containing preparations on an individual basis.

Indigenous plants have long been used by African populations in their cultural lives and health care. Sutherlandia frutescens (SF) is a popular traditional medicinal plant found in various parts of southern Africa and used for treatment or management of different diseases, including cancer and HIV/AIDS. In this study, the biochemical effects of various dilutions (1/50, 1/150, 1/200, and 1/300) of SF 70% ethanol (SFE) and deionised water (SFW) extracts in cancerous H9 and normal T cells were examined. Untreated, 70% ethanol-treated and camptothecin (CPT, 20jiiM) treated cells were used as reference samples for comparison. Cytotoxicity, apoptotic enzymes activity, oxidant scavenging and antioxidant promoting abilities, cellular morphology and cytokine signalling effects were assessed using the methylthiazol tetrazolium (MTT) assay, adenosine triphosphate (ATP) assay, caspase-3/-7 activity assay, thiobarbituric acid reactant substance (TBARS) and glutathione (GSH) assays, fluorescence microscopy and an ELISAbased cytokine analyses assay respectively. Sutherlandia frutescens ethanol and water extract dilutions (1/50 and 1/200) were shown to be cytotoxic to H9 T cells in a dose- and time-dependent manner with the SFE extract having an average IC50 of 1/40 after 24 hours while SFW extract reached a similar IC50 only after 48 hours. In normal T cells, the SFE extract induced proliferation after 24 hours but this was reverse after 48 hours. The SFW extract dilutions did not significantly change cell viability after 24 hours but significantly increased cell viability after 48 hours. Both SFE and SFW extracts dilutions induced a dose- and time-dependent inhibition of caspase-3/-7 activity in both H9 and normal T cells. Both types of extracts were also shown to efficiently remove lipid peroxides from supernatants of treated cell lines, with SFW extract having a more lasting effect. In the GSH assay, the SFE and SFW extract dilutions reduced GSH levels in H9 T cells, with the SFW extract dilutions being more effective. In normal T cells, the higher dilutions (1/150 and 1/300) of SFW extract increased GSH levels significantly while lower dilutions (1/50) of both SFE and SFW extracts significantly inhibited GSH levels. Lower dilutions (1/50) of SFE and SFW extracts induced chromatin condensation in both H9 and normal T cells after 48 hours incubation. Using treated peripheral blood mononuclear cells (PBMCs) supernatants, SFE and SFW extract dilutions were shown to reduce the levels of pro-inflammatory cytokines IL 1 p and TNF-a in a dose-dependent manner. These results further confirmed the anticancer abilities of SF and showed that higher concentrations of this medicinal plant can be toxic to normal T cells in vitro while lower concentrations can stimulate the immune cells. Therefore further studies should be conducted with regards to the effects of SF on the immune system in both in vitro and in vivo systems. / Thesis (M.Med.Sci.)-University of KwaZulu-Natal, 2008.

Thesis (MSc)--Stellenbosch University, 2013. / ENGLISH ABSTRACT: Sutherlandia frutescens (L.) R. Br., also known as Lessertia frutescens, is a leguminous shrub indigenous to southern Africa. Traditionally this plant has been used for the treatment of various ailments; current interest in this plant has escalated after it was announced that extracts could aid in the relief and treatment of HIV/AIDS. These extracts contain an array of metabolites, including sutherlandins, sutherlandiosides L-arginine, L-canavanine, asparagine, gamma-aminobutyric acid (GABA), and various other amino acids, which have been linked to medicinal uses. This study focused on the use of hormones to promote the growth and metabolite production of S. frutescens in vitro cultures. The growth promoting substances used in this study were synthetic analogues of strigolactones, GR24 and Nijmegen-1, and auxins, indole-3-butyric acid (IBA) and naphthalene acetic acid (NAA). The first part of this study focused on the effects strigolactones and auxins, alone and combined, had on the growth of S. frutescens in vitro nodal explants. The S. frutescens nodal explants had the most significant improvement in growth with treatments that contained 1 mg/L NAA. These treatments increased growth via fresh and dry mass and plant length. The metabolite content of these nodal explant cultures was evaluated using liquid chromatography/mass spectrometry (LC/MS) metabolite analysis. The treatments that contained 1 mg/L NAA differed in metabolite composition and showed an increase in metabolite quantity. The SU1 content of the treated plants was also quantified using LC/MS techniques and a combination of 1 mg/L NAA and Nijmegen-1 doubled the amount of SU1. The effect of strigolactones was also studied using hairy root cultures of S. frutescens. Strigolactones alone slightly inhibited the formation of lateral transgenic roots, but when these chemicals were used in combination with auxins, significant reduction in dry mass and lateral root outgrowth resulted. Of the treatments tested in this study, 0.1 mg/L IBA caused noticeable alterations to the metabolite pool, with amino acids such as GABA and arginine accumulating at higher levels than the control explants. The exploitation of hormones to up-regulate the growth and metabolism of the medicinally important plant, Sutherlandia frutescens, proved successful in this study. The use of in vitro nodal explants along with hairy root cultures has assisted in the establishment of a stable system for the up-regulation of metabolites. / AFRIKAANSE OPSOMMING: Sutherlandia frutescens (L.) R. Br., ook bekend as Lessertia frutescens, is 'n peulagtige struik inheems tot suider Afrika. Tradisioneel is die plant vir 'n groot verskeidenheid van kwale gebruik; huidige belangstelling in die plant het toegeneem nadat dit bekend gemaak was dat ekstraksies vanaf hierdie plant verligting kan bied vir MIV/VIGS. Hierdie ekstrakte bevat 'n verskeidenheid van metaboliete, insluitend sutherlandins, sutherlandiosiede L-arginien, L-kanavanien, asparagien, gamma-aminobottersuur (GABS), asook verskeie ander aminosure wat medisinale gebruike het. Die studie het gefokus op die gebruik van hormone om die groei en metaboliete van S. frutescens in vitro kulture te vermeerder. Die groei reguleerders wat in hierdie studie gebruik was, was die sintetiese analoë van strigolaktoon, GR24 en Nijmegen-1, asook die ouksiene, indool-3-bottersuur (IBS) en naftaleen asynsuur (NAS). Die eerste deel van die studie het gefokus op die effek van strigolaktoon en ouksien, alleen en in kombinasie, op die groei van S. frutescens in vitro nodale mikrostingels. Die S. frutescens nodale mikrostingels wat behandel was met 1 mg/L NAS het die aansienlikste toename in groei getoon. Hierdie behandeling het groei bevorder deur middel van vars en droë massa en plant lengte. Die metaboliet inhoud van die behandelde mikrostingels was met behulp van vloeistofchromatografie/massa spektrometrie (VC/MS) ondersoek. Al die behandelinge wat 1 mg/L NAS bevat het, het in metaboliet samestelling verskil en het ook 'n toename in metaboliet hoeveelheid getoon. Die SU1 inhoud van die behandelde plante was ook met behulp van VC/MS tegnieke gekwantifiseer en dit was gevind dat 'n kombinasie van 1 mg/L NAS en Nijmegen-1 die hoeveelheid SU1 verdubbel het. Die effek van strigolaktoon op harige wortel kulture van S. frutescens was ook ondersoek. Strigolaktoon alleen het die formasie van laterale transgeniese wortels effens inhibeer, maar wanneer hierdie chemikalieë saam met ouksiene gebruik was, was die aansienlike afname van die massa en inhibisie van die laterale wortel uitgroeisels meer prominent. Van al die behandelinge wat in hierdie studie getoets is, het 0.1 mg/L IBS die mees merkbare veranderinge in metaboliete meegebring en aminosure soos GABS en arginien het teen hoër vlakke versamel. Die uitbuiting van hormone om groei en metaboliet produksie te bevorder in die belangrike medisinale plant, Sutherlandia frutescens, was suksesvol in hierdie studie. Die gebruik van nodale mikrostingels asook harige wortel kulture het bygedra om 'n stabiele sisteem te vestig vir die vermeerdering van metaboliete.

Magister Scientiae - MSc / The overall aims of this project were to assess the pharmaceutical quality and consistency of commercially available solid dose Sutherlandia frutescens containing products (viz. tablets & capsules) by exploring the use of monitoring the pharmaceutical presentation, flavonoid profile and antioxidant activity levels and to develop/or adapt methods and specifications that may be used for the quality control of such products.Stability tests were conducted on all of the selected SCP. The products were stored under elevated temperatures and environmental humidity conditions and total phenol, antioxidant and chromatographic analysis was conducted on these samples. Samples of each of the SCP were hydrolyzed using HCL and then analyzed using HPLC to test the stability of the flavonoids present in each product. The SCP investigated in this study physically appeared to be of quite good “pharmaceutical” quality, but generally lacked information on the date of manufacture and lacked package inserts, or when these were present they contained insufficient information. Based on the results obtained, it is recommended that, the manufacturers of SCP pay more attention to the information provided on the package inserts and the storage conditions for their products. Further the levels of antioxidant activity, total phenols and flavonoid (sutherlandins A to D) be used as specifications to control the quality of commercially available solid dose Sutherlandia frutescens containing preparations on an individual basis. / South Africa

Philosophiae Doctor - PhD / Various formulations of the popular South African medicinal plant, Sutherlandia frutescens,are commercially available, with no documented specifications for quality assessment. With plans already underway for a clinical trial to assess its efficacy in HIV patients, there is a need for scientifically validated tests for the quality control of products of this plant. Chemical constituents of the plant are many and varied but it is still unclear which might be the most appropriate ones to monitor for activity or to describe the quality of the plant’s products. For quality control and regulatory purposes, the content and dissolution of flavonoids in the plant products can be assessed. However, these compounds are not monitored for regulation and there are as yet no HPLC or dissolution methods that can be employed for quality control of herbals like S. frutescens. Therefore, the objectives of this study were to assess the suitability of its flavonoid constituents as quality control (QC) marker compounds, and the suitability of content levels and dissolution tests of flavonoids as QC tools for S. frutescens products. To realise the afore-mentioned objectives, non-commercially available flavonoid compounds (sutherlandins) that could be used as marker compounds were isolated from S. frutescens. An HPLC assay was developed and validated for determination of flavonoid content in solution. Five S. frutescens materials viz leaf powder (LP), spray-dried aqueous extract (SDAE) and freeze-dried aqueous extracts (FDAE) were analysed for flavonoid content and dissolution. Dissolution tests were conducted for different S. frutescens materials and dissolution profiles of flavonoids in capsules containing these materials were compared using Q-release values, the similarity factor (f2) and mathematical models. To predict in vivo bioavailability of the flavonoids, in silico assessment of in vivo bioavailability of flavonoids (glycosides and aglycones) that may be contained in different S. frutescens materials was conducted. Sutherlandins A, B, C and D were successfully isolated (percentage purity approximately99 % for sutherlandins A, C and D, and 90 % for sutherlandin B) and identified, and used, along with other flavonoid compounds, for the development of a simple and robust HPLC method. Content of sutherlandins A, B, C and D, quercetin and kaempferol in different plant materials were 0.4 ± 0.3, 0.8 ± 0.2, 1.3 ± 0.2, 0.6 ± 0.1, 0.01 ± 0.02 and 0.08 ±0.1 %,respectively, and differed significantly (p < 0.001). In vitro dissolution showed faster dissolution of flavoniod glycosides compared to aglycones. The flavonoids from the LP and SDAE materials showed characteristics of immediate release with Q75 in ≤ 45 minutes, and delayed release from the FDAE material, i.e. Q75 > 45 minutes. The dissolution profiles of each flavonoid compared from different S. frutescens materials were different as signified by their f2 values which were all below 50. The mathematical models describing release were also different for each flavonoid from the different S. frutescens materials. For in vivo bioavailability modelling and prediction studies, the flavonoid aglycones met the conditions for oral bioavailability while the flavonoid glycosides did not. In conclusion, the sutherlandins isolated from S. frutescens proved to be good markers for HPLC assay and dissolution tests of S. frutescens materials. The HPLC method was suitable for assessing flavonoid levels in S. frutescens materials, and also showed differences in flavonoid content in these materials. The dissolution method was simple and reproducible, and Q-release values, the f2 and mathematical models proved to be good tools for differentiating between S. frutescens materials. In silico modelling showed that the flavonoid glycosides and aglycones differed in oral bioavailability. Although not presently required by the Medicines Control Council (MCC), quantification, release and dissolution studies and specifications may be employed as tools for routine analysis and for quality control of herbal drug formulations containing S. frutescens.

Magister Pharmaceuticae - MPharm / Sutherlandia frutescens is a traditional plant medicine widely used in South Africa. Traditionally, the leaves of S. frutescens are mainly used as a tea, but these traditional dosage forms have several disadvantages, including that they are not particularly convenient to prepare and store, encourage dosage inaccuracy and are highly susceptible to microbial contamination. To solve these problems, dried aqueous extract forms, e.g. freeze dried aqueous extract (FDAE) of S. frutescens were prepared, but they, in turn, may still suffer from instability and contain mainly hydrophilic phytoconstituents that are poorly absorbed and delivered for in vivo activity. Modified forms of the FDAE, i.e. the active phytopharmaceutical ingredient (API), may be a better solution. Therefore this study sought to prepare liposomes and phytosomes of the freeze dried aqueous extract of Sutherlandia frutescens, as a means of increasing the total the surface area of the API, thus improving its release and dissolution in gastrointestinal fluids. Liposomes and phytosomes of the FDAE of Sutherlandia frutescens obtained were prepared using a thin film hydration method at ratios of lecithin: S. frutescens (3:1) and phosphatidylcholine: S. frutescens (2:1) respectively. The physical characteristics (i.e. particle size, size distribution, zeta potential, and morphology), of flavonoid glycosides (i.e. sutherlandins A to D; API) as well as content and release profiles of each dosage form (i.e. FDAE liposome or phytosomes) at pH 1.2 and pH 6.8 was determined. A validated HPLC assay was used to determine and compare the flavonoid glycoside content and release profiles of the liposomes and phytosomes. Both liposomes and phytosomes were successfully prepared, in moderate yields (± 30 %, and ± 50 %, respectively), using the thin film hydration method. The liposomes had a significantly smaller size, lower size distribution, higher zeta potential and better stability than the phytosomes (p < 0.05). The phytosomes, however, had significantly higher flavonoid glycoside encapsulation efficiency than the liposomes (±50 % vs ±26 %; p < 0.01). In addition, the release at 120 minutes, of flavonoid glycosides from the liposomes (63%, 58%, 76% and 46% % at pH 1.2, and 78%, 76%, 87% and 89 % at pH 6.8 for sutherlandins A, B, C and D, respectively) was significantly higher and faster than that of the phytosomes (52%, 41%, 51% and 39 % at pH 1.2, and 31% 31%, 33%and 45% % at pH 6.8, for sutherlandins A, B, C and D, respectively). The differences in release were likely due to differences in particle size and size distribution of the two modified API forms. Overall, liposomes and phytosomes can be considered promising vehicles for delayed delivery of herbal crude extracts. Based on its characteristics (i.e. narrower size distribution, and better stability), the liposomes were preferred compared to the phytosomes offering a better kinetic release profile. The phytosomes had higher encapsulation than the liposomes that may be due to complex formation between the API and the lipid.

M.Sc.